In-Person Access Only | 8.0 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
Total Health's 2026 Best of ASCO® Anchorage Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Program Chairs:
Ravi Salgia, MD (City of Hope)
Ann Partridge, MD (Dana-Farber Cancer Institute)
Conference Agenda
Saturday, July 18, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
Ann Partridge, MD, MPH | Dana Farber Cancer Institute
8:40 AM
Colorectal Cancer
Gagandeep Brar, MD | City of Hope
9:10 AM
Non-Colorectal Cancer
Lipika Goyal, MD | Stanford
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Exelixis - A Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Sandy Liu, MD | University of California, Irvine
10:40 AM
Head and Neck Cancer
Aditya Shreenivas, MD | City of Hope
11:10 AM
Sarcomas and Rare Cancers
Min S. Park, MD | Fred Hutch Cancer Center
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Regeneron
12:40 PM
Housekeeping and Survey
12:50 PM
Leukemia
Chelby Wakefield, MD | Banner Health
1:20 PM
Lymphoma
Bhagirathbhai Dholaria, MD, FACP | Vanderbilt University Medical Center
1:50 PM
Multiple Myeloma
Richa Thakur, MD | Fred Hutch Cancer Center
2:20 PM
Melanoma
Vincent Ma, MD | UW Health
2:50 PM
Adjourn
Sunday, July 19, 2026
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Ravi Salgia, MD | City of Hope
8:10 AM
Small Cell Lung Cancer
Millie Das, MD | Stanford
8:40 AM
Non-Small Cell Lung Cancer
Siddhartha Devarakonda, MD | Swedish
9:10 AM
Lung Cancer Panel
Ravi Salgia, MD | City of Hope
Millie Das, MD | Stanford
Siddhartha Devarakonda, MD | Swedish
9:40 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Siddhartha Devarakonda, MD | Swedish
10:00 AM
Breakfast and Exhibits
10:25 AM
Non-CME Breakfast - Pfizer Elrexfio - Learn More About Getting Started and Transitioning to Outpatient Care for Patients With Relapsed or Refractory Multiple Myeloma
Dr. Hakan Kaya | Cancer Care Northwest in Spokane, Washington
11:10 AM
Early-Stage Breast Cancer
Ann Partridge, MD, MPH | Dana Farber Cancer Institute
11:40 AM
Metastatic Breast Cancer
Reshma Mahtani, DO | Baptist Health South Florida
12:10 PM
Lunch and Exhibits
12:55 PM
Non-CME Lunch - Pfizer Breast - Treatment Considerations for Patients With HR+/HER2- mBC
Reshma Mahtani, DO | Baptist Health South Florida
1:10 PM
Survivorship
Beth Dupree | The Healing Consciousness Foundation
1:40 PM
Prostate Cancer
Brad Somer, MD | West Clinic
2:10 PM
Non-Prostate Cancer
Umang Swami, MD, MSCI, FASCO | University of Utah
2:40 PM
Adjourn
Agenda Subject To Change. All times are AKST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.5 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program